Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-0,60
KB-2,67
PKN121,28121,5-3,67
Msft-2,77
Nokia6,3266,384-9,16
IBM0,25
Mercedes-Benz Group AG37,29537,49-1,69
PFE-0,51
21.11.2026 1:38:45
Indexy online
AD Index online
select
AD Index online
 

  • 20.11.2026
Cochlear Ltd (COH.F, Frankfurt)
Závěr k 20.11.2026 Změna (%) Změna (EUR) Objem obchodů (EUR)
89,84 -3,87 -3,62 3 234
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 21.11.2026
Popis společnosti
Obecné informace
Název společnostiCochlear Ltd
TickerCOH
Kmenové akcie:Fully Paid Ord. Shrs
RICCOH.AX
ISINAU000000COH5
Poslední známé roční výsledky30.06.2025
Poslední známé čtvrtletní výsledky30.06.2025
Počet zaměstnanců k 30.06.2025 5 500
Akcie v oběhu k 30.06.2025 65 397 004
MěnaAUD
Kontaktní informace
Ulice1 University Avenue
MěstoSYDNEY
PSČ2109
ZeměAustralia
Kontatní osoba 
Funkce kontaktní osoby 
Telefon61 294 286 555
Fax61294286352

Business Summary: Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services, and Acoustics. Cochlear Implants segment offers Cochlear implant systems. Services segment offers sound processor upgrades, accessories and other. Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Its Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Financial Summary: BRIEF: For the fiscal year ended 30 June 2025, Cochlear Ltd revenues increased 5% to A$2.34B. Net income increased 9% to A$388.9M. Revenues reflect Asia Pacific segment increase of 15% to A$428.8M, EMEA segment increase of 6% to A$789.7M, Asia Pacific segment increase of 15% to A$428.8M, EMEA segment increase of 6% to A$789.7M. Net income benefited from Integration costs decrease from A$28.2M (expense) to A$0K.
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Medical Prosthetics
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICS2007Electromedical Apparatus Mfg
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
SICElectromedical Equipment



  • Poslední aktualizace: 21.11.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Member of the Executive BoardTurkka Kuusisto4624.04.202424.04.2024
Deputy Chief Executive Officer, Member of the Executive BoardJaakko Schildt5310.09.2024
Chief Financial Officer, Member of the Executive BoardPia Aaltonen-Forsell5101.08.202501.08.2025
Chief People Officer, Member of the Executive BoardKaisa Aalto-Luoto4623.11.202323.11.2023
Senior Vice President, General Counsel, Member of the Executive BoardSami Sarelius5420.08.201020.08.2010
Senior Vice President - Communications, Member of the Executive BoardPaivyt Tallqvist5401.11.202001.11.2020
Chief Digital Officer, Member of the Executive BoardAntti Kleemola4410.09.202401.06.2022
Chief Customer Officer, Member of the Executive BoardSimon Large5401.10.202401.10.2024
Chief Revenue Officer, Member of the Executive BoardChristine Rovelli5010.09.202401.10.2022